HLA class 1 associations in Henoch Schonlein purpura: Increased and decreased frequencies

Clinical Rheumatology

Volumn 27, Issue 1, 2008, Pages 5-10

  Peru, Harun ^a   Soylemezoglu, Oguz ^a   Gonen, Sevim ^a   Cetinyurek, Aysun ^b   Bakkaloğlu, Sevcan Azime ^a   Buyan, Necla ^a   Hasanoglu, Enver ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Henoch Schonlein purpura; Human leukocyte antigen; Susceptibility

Indexed keywords

CYCLOPHOSPHAMIDE; HLA ANTIGEN CLASS 1; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ACUTE KIDNEY FAILURE; ALLELE; ANAPHYLACTOID PURPURA; ARTHROPATHY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; FISHER EXACT TEST; FREQUENCY ANALYSIS; GASTROINTESTINAL SYMPTOM; GENE AMPLIFICATION; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MARKER; HEMATURIA; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RACE DIFFERENCE; RISK; SKIN DISEASE;

EID: 36549053185     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0640-z     Document Type: Article

References (18)

1. Jin DK, Kohsaka T, Koo JW et al (1996) Complement 4 locus II gene deletion and DQA1*0301 gene: Genetic risk factors for IgA nephropathy and Henoch Schonlein nephritis. Nephron 73:390-395
2. Amoroso A, Berrino M, Canale L et al (1997) Immunogenetics of Henoch-Schonlein disease. Eur J Immunogenet 24:323-333
3. Amoli MM, Thomson W, Hajeer AH et al (2002) HLA B*35 association with nephritis in Henoch-Schonlein purpura. J Rheumatol 29:948-949
4. Amoli MM, Thomson W, Hajeer AH et al (2001) HLA-DRB1*01 association with Henoch-Schonlein purpura in patients from Northwest Spain. J Rheumatol 28:1266-1270
5. Mills JA, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114-1121
6. Soylemezoglu O, Ozkaya O, Erbas D et al (2002) Nitric oxide in Henoch Schonlein purpura. Scand J Rheumatol 31:271-274
7. Dababneh A, González-Gay MA, Garcia-Porrua C et al (1998) Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 25:2140-2145
8. Weyand CM, Hicock KC, Hunder GG et al (1992) The HLA DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA DR molecule. J Clin Invest 90:2355-2361
9. Weyand CM, Hunder NN, Hicock KC et al (1994) HLA DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 37:514-520
10. Combe B, Sany J, Le Quellec A et al (1998) Distribution of HLA DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol 25:94-98
11. Rauzy O, Fort M, Nourhashemi F et al (1998) Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 57:380-382
12. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 5:283-292
13. Glass D, Soter NA, Gibson D et al (1976) Association between HLA and cutaneous necrotizing venulitis. Arthritis Rheum 19:945-949
14. Ostergaard JR, Storm K, Lamm LU (1990) Lack of association between HLA and Schonlein-Henoch purpura. Tissue Antigens 35:234-235
15. Nathwani D, Laing RB, Smith CC et al (1992) Recurrent post-infective Henoch Schonlein syndrome: A genetic influence related to HLA B35?. J Infect 25:205-210
16. Nyulassy S, Buc M, Sasinka M et al (1977) The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319-323
17. Freycon MT, Parchoux B, Dechelette E et al (1984) HLA and rheumatoid purpura with or without nephropathy. Pediatrie 39:525-532
18. Arellano J, Ojeda S, Vargas R et al (1990) Histocompatibility antigens and acute vascular purpura. Bol Med Hosp Infant Mex 47:620-623